Literature DB >> 8520396

Prognostic trees to aid prognosis in patients with cutaneous malignant melanoma. Scottish Melanoma Group.

T C Aitchison1, J M Sirel, D C Watt, R M MacKie.   

Abstract

OBJECTIVES: To design user friendly guides to prognosis for patients who have had invasive primary cutaneous malignant melanomas surgically excised.
DESIGN: Adaptation of the classification tree method was used to derive prognostic trees for four different subgroups of malignant melanoma patients in whom known and possible prognostic variables interacted in different ways.
SETTING: Scotland.
SUBJECTS: Statistical modelling for prognostic trees was based on 1978 patients whose primary malignant melanoma was first diagnosed in 1979-86 for whom five year follow up and all relevant clinical pathological data were available. The resultant model was validated with 300 patients first diagnosed in 1987 for whom the same information was available. MAIN OUTCOME MEASURES: Actual and predicted rate of survival after diagnosis of primary cutaneous malignant melanoma.
RESULTS: The four subgroups of patients were men and women with ulcerated and non-ulcerated cutaneous primary melanomas. Validation of the model showed excellent agreement between actual status of patients in the relevant subgroups and their status as predicted by the model.
CONCLUSIONS: The prognostic trees are simple to use and give more accurate prognosis for individual patients than is currently available from tumour thickness alone.

Entities:  

Mesh:

Year:  1995        PMID: 8520396      PMCID: PMC2548224          DOI: 10.1136/bmj.311.7019.1536

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  3 in total

Review 1.  Influence of gender on survival in patients with stage I malignant melanoma.

Authors:  K A Vossaert; M K Silverman; A W Kopf; R S Bart; D S Rigel; R J Friedman; M Levenstein
Journal:  J Am Acad Dermatol       Date:  1992-03       Impact factor: 11.527

2.  Model predicting survival in stage I melanoma based on tumor progression.

Authors:  W H Clark; D E Elder; D Guerry; L E Braitman; B J Trock; D Schultz; M Synnestvedt; A C Halpern
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

3.  Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86, and their subsequent validation.

Authors:  R M MacKie; T Aitchison; J M Sirel; K McLaren; D C Watt
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

  3 in total
  6 in total

1.  Factors affecting a climber's ability to ascend Mont Blanc.

Authors:  G Tsianos; L Woolrich-Burt; T Aitchison; A Peacock; M Watt; H Montgomery; I Watt; S Grant
Journal:  Eur J Appl Physiol       Date:  2005-10-19       Impact factor: 3.078

2.  Development and Validation of a Simple Risk Model for Predicting Metabolic Syndrome (MetS) in Midlife: A Cohort Study.

Authors:  Musa S Ibrahim; Dong Pang; Gurch Randhawa; Yannis Pappas
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-06       Impact factor: 3.168

Review 3.  Structured reporting to improve transparency of analyses in prognostic marker studies.

Authors:  Willi Sauerbrei; Tim Haeussler; James Balmford; Marianne Huebner
Journal:  BMC Med       Date:  2022-05-12       Impact factor: 11.150

4.  Melanoma survivorship: research opportunities.

Authors:  Susan A Oliveria; Jennifer L Hay; Alan C Geller; Maureen K Heneghan; Mary S McCabe; Allan C Halpern
Journal:  J Cancer Surviv       Date:  2007-03       Impact factor: 4.442

5.  Comparing the Modified Frailty Index with conventional scores for prediction of cardiac resynchronization therapy response in patients with heart failure.

Authors:  Ajay Raj; Ranjit Kumar Nath; Bhagya Narayan Pandit; Ajay Pratap Singh; Neeraj Pandit; Puneet Aggarwal
Journal:  J Frailty Sarcopenia Falls       Date:  2021-06-01

6.  Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.

Authors:  Tanya Walsh; Richard Macey; Alexander R Kerr; Mark W Lingen; Graham R Ogden; Saman Warnakulasuriya
Journal:  Cochrane Database Syst Rev       Date:  2021-07-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.